|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | August 21, 2001 | ||||||||
| Last Updated Date | August 24, 2009 | ||||||||
| Start Date ICMJE | August 2001 | ||||||||
| Estimated Primary Completion Date | June 2011 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE | |||||||||
| Original Primary Outcome Measures ICMJE | |||||||||
| Change History | Complete list of historical versions of study NCT00023036 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | |||||||||
| Original Secondary Outcome Measures ICMJE | |||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Clinical and Genetic Analysis of Enlarged Vestibular Aqueducts | ||||||||
| Official Title ICMJE | Clinical and Molecular Analysis of Enlarged Vestibular Aqueducts | ||||||||
| Brief Summary | This study will try to identify and understand the genetic factors that lead to inner ear malformation called "enlarged vestibular aqueducts", that can lead to hearing loss. Patients with sensorineural hearing loss with or without inner ear malformations and their parents and siblings may be eligible for this study. Participants and their immediate family members, may undergo some or all of the following tests and procedures:
|
||||||||
| Detailed Description | Nonsyndromic hereditary hearing impairment is a genetically heterogeneous disorder that can be caused by mutations in any one of at least 60 different genes. Enlargement of the vestibular aqueduct (EVA) is a radiologic finding known to be associated with mutations in one of these genes, the Pendred syndrome gene (PDS). EVA may thus serve as a clinically useful marker to facilitate the diagnosis of hearing impairment. Recent data from our laboratory and others indicates that only a subset of individuals with EVA have PDS mutations, and therefore some EVA cases are likely to be caused by other genes, nongenetic factors, or a combination of these etiologies. Individuals with hearing impairment and EVA will be enrolled in this study in order to: (1) Prospectively determine the prevalence of PDS mutation in EVA patients; (2) correlate phenotypic features with PDS genotype status; 3) identify other genetic factors that cause EVA. Siblings and parents may also be enrolled in order to define inheritance and to perform molecular genetic analyses. |
||||||||
| Study Phase | |||||||||
| Study Type ICMJE | Observational | ||||||||
| Study Design ICMJE | Other | ||||||||
| Condition ICMJE |
|
||||||||
| Intervention ICMJE | |||||||||
| Study Arms / Comparison Groups | |||||||||
| Publications * |
|
||||||||
|
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Enrollment ICMJE | 500 | ||||||||
| Completion Date | |||||||||
| Estimated Primary Completion Date | June 2011 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE |
Patients with known or suspected nonsyndromic SNHL associated with inner ear malformations will be recruited. Eligibility requires two or more participating affected family members since they are needed for genetic mapping approaches to identify genes in which mutations cause EVA, with the exception of sporadic cases with distinctive phenotypic features that may provide insight in to novel etiologies of EVA. Siblings and biological parents of study subjects with SNHL and inner ear malformations will also be eligible in order to identify subclinical phenotypes, determine the mode of inheritance, and facilitate the molecular genetic analyses. Referrals will be accepted from otolaryngologists, audiologists, medical geneticists, genetic counselors, other health care professionals, as well as self-referrals from potential study subjects and their family members. Given the rarity of these disorders, referrals will be accepted worldwide and subjects from all ethnic backgrounds will be recruited. EXCLUSION CRITERIA: Patients known to be exposed to physical or chemical teratogens in utero may be excluded because their inner ear malformations could be due to these nongenetic etiologies (e.g., thalidomide, radiation, etc.). Hearing loss that is associated with previously described syndromes such as bronchio-oto-renal (BOR) syndrome. |
||||||||
| Gender | Both | ||||||||
| Ages | |||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | United States | ||||||||
| Administrative Information | |||||||||
| NCT ID ICMJE | NCT00023036 | ||||||||
| Responsible Party | |||||||||
| Study ID Numbers ICMJE | 010228, 01-DC-0228 | ||||||||
| Study Sponsor ICMJE | National Institute on Deafness and Other Communication Disorders (NIDCD) | ||||||||
| Collaborators ICMJE | |||||||||
| Investigators ICMJE | |||||||||
| Information Provided By | National Institutes of Health Clinical Center (CC) | ||||||||
| Verification Date | June 2009 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||